<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RPRX
Royalty Pharma
$
()


  • Royalty Pharma price target lowered by $20 at Citi, here's why

    10/25/2024 - 06:22am
  • PureTech Health announces FDA approval of KarXT

    9/27/2024 - 05:56am
  • Royalty Pharma price target raised by $1 at Goldman Sachs, here's why

    8/13/2024 - 17:10pm
  • DRI Healthcare Trust just upgraded at Stifel, here's why

    8/12/2024 - 18:41pm
  • Royalty Pharma reports Q2 revenue $537M, consensus $628.52M

    8/8/2024 - 07:35am
  • Royalty Pharma appoints Sawaya as EVP, Head of Human Capital

    7/24/2024 - 08:40am
  • Royalty Pharma price target raised by $3 at Morgan Stanley, here's why

    7/11/2024 - 08:15am
  • Agios Pharmaceuticals price target raised by $9 at RBC Capital, here's why

    6/3/2024 - 14:30pm
  • UBS gets more bearish on Royalty Pharma, downgrades shares

    6/3/2024 - 08:53am
  • Biotech Alert: Searches spiking for these stocks today

    5/30/2024 - 11:04am
  • Royalty Pharma, Agios enter into vorasidenib royalty agreement

    5/28/2024 - 07:15am
  • Agios Pharmaceuticals announces $905M purchase agreement for vorasidenib royalty

    5/28/2024 - 07:03am
  • Cytokinetics price target lowered by $22 at Raymond James, here's why

    5/23/2024 - 08:53am
  • Cytokinetics price target lowered by $36 at Needham, here's why

    5/23/2024 - 08:09am
  • Fly Intel: After-Hours Movers

    5/22/2024 - 19:42pm
dynamic_feed Breaking News